The avalanche is coming... and just now it's starting to snow

Frontiers in Immunology

Volumn 4, Issue JUN, 2013, Pages

  Aspinall, Richard ^a   Lang, Pierre Olivier ^b  

^a CRANFIELD UNIVERSITY   (United Kingdom)

^b Nescens Centre of Preventive Medicine   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; INTERLEUKIN 7; VALACICLOVIR;

AGING; ARTICLE; BACTERIAL INFECTION; BED REST; COUGHING; CYTOMEGALOVIRUS INFECTION; DISEASE TRANSMISSION; HEMAGGLUTINATION INHIBITION; HERPES VIRUS INFECTION; HUMAN; IMMUNE RESPONSE; INFLUENZA; LIFE EXPECTANCY; NONHUMAN; NUTRITIONAL STATUS; PNEUMONIA; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; VACCINATION;

EID: 84883768731     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00165     Document Type: Article

References (29)

1. Ademokun, A., Wu, Y. C., Martin, V., Mitra, R., Sack, U., and Baxendale, H. (2011). Vaccination-induced changes in human B-cell repertoire and pneumococcal IgM and IgA antibody at different ages. Aging Cell 10, 922-930. doi:10.1111/j.1474-9726.2011.00732.x
2. Aspinall, R., Pido-Lopez, J., Imami, N., Henson, S. M., Ngom, P. T., and Morre, M. (2007). Old rhesus macaques treated with interleukin-7 show increased TREC levels and respond well to influenza vaccination. Rejuvenation Res. 10, 5-17. doi:10.1089/rej.2006.9098
3. Beswick, M., Pachnio, A., Lauder, S. N., Sweet, C., and Moss, P. A. (2013). Antiviral therapy can reverse the development of immune senescence in elderly mice with latent cytomegalovirus infection. J. Virol. 87, 779-789. doi:10.1128/JVI.02427-12
4. Chidrawar, S. M., Khan, N., Chan, Y. L., Nayak, L., and Moss, P. A. (2006). Ageing is associated with a decline in peripheral blood CD56bright NK cells. Immun. Ageing 3, 10. doi:10.1186/1742-4933-3-10
5. Collerton, J., Davies, K., Jagger, C., Kingston, A., Bond, J., and Eccles, M. P. (2009). Health and disease in 85 year olds: baseline findings from the Newcastle 85+ cohort study. BMJ 339, b4904. doi:10.1136/bmj.b4904
6. Dimond, S., and Harries, R. (1984). Face touching in monkeys, apes and man evolutionary origins and cerebral asymmetry. Neuropsychologia 22, 227-233. doi:10.1016/0028-3932(84)90065-4
7. Field, V., Gautret, P., Schlagenhauf, P., Burchard, G. D., Caumes, E., and Jensenius, M. (2010). Travel and migration associated infectious diseases morbidity in Europe, 2008. BMC Infect. Dis. 10, 330. doi:10.1186/1471-2334-10-330
8. Gautret, P., Gaudart, J., Leder, K., Schwartz, E., Castelli, F., and Lim, P. L. (2012). Travel-associated illness in older adults (>60 y). J. Travel Med. 19, 169-177. doi:10.1111/j.1708-8305.2012.00613.x
9. Govaert, T. M., Thijs, C. T., Masurel, N., Sprenger, M. J., Dinant, G. J., and Knottnerus, J. A. (1994). The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 272, 1661-1665. doi:10.1001/jama.1994.03520210045030
10. Hannoun, C., Megas, F., and Piercy, J. (2004). Immunogenicity and protective efficacy of influenza vaccination. Virus Res. 103, 133-138. doi:10.1016/j.virusres.2004.02.025
11. Kramer, A., Schwebke, I., and Kampf, G. (2006). How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect. Dis. 6,130. doi:10.1186/1471-2334-6-130
12. Lang, P. O., and Aspinall, R. (2012). Immunosenescence and herd immunity: with an ever-increasing aging population do we need to rethink vaccine schedules? Expert Rev. Vaccines 11, 167-176. doi:10.1586/erv.11.187
13. Lang, P. O., Govind, S., Mitchell, W. A., Siegrist, C. A., and Aspinall, R. (2011). Vaccine effectiveness in older individuals: what has been learned from the influenza-vaccine experience. Ageing Res. Rev. 10, 389-395. doi:10.1016/j.arr.2010.09.005
14. Langkamp-Henken, B., Wood, S. M., Herlinger-Garcia, K. A., Thomas, D. J., Stechmiller, J. K., and Bender, B. S. (2006). Nutritional formula improved immune profiles of seniors living in nursing homes. J. Am. Geriatr. Soc. 54, 1861-1870. doi:10.1111/j.1532-5415.2006.00982.x
15. Lofgren, J. P. (2011). Available at: http://www.socialdistancing.org/determining-your-social-distance-group-plan/
16. McElhaney, J. E. (2005). The unmet need in the elderly: designing new influenza vaccines for older adults. Vaccine 23(Suppl. 1), S10-S25. doi:10.1016/j.vaccine.2005.04.019
17. Michel, J. P., Lang, P. O., and Baeyens, J. P. (2009). Flu vaccination policy in old adults: need for harmonization of national public health recommendations throughout Europe. Vaccine 27, 182-183. doi:10.1016/j.vaccine.2008.10.072
18. Michel, J. P., Newton, J. L., and Kirkwood, T. B. (2008). Medical challenges of improving the quality of a longer life. JAMA 299, 688-690. doi:10.1001/jama.299.6.688
19. Mitchell, W. A., Lang, P. O., and Aspinall, R. (2010). Tracing thymic output in older individuals. Clin. Exp. Immunol. 161, 497-503. doi:10.1111/j.1365-2249.2010.04209.x
20. Monto, A. S., Ansaldi, F., Aspinall, R., McElhaney, J. E., Montano, L. F., and Nichol, K. L. (2009). Influenza control in the 21st century: optimizing protection of older adults. Vaccine 27, 5043-5053. doi:10.1016/j.vaccine.2009.06.032
21. Murabito, J. M., Yuan, R., and Lunetta, K. L. (2012). The search for longevity and healthy aging genes: insights from epidemiological studies and samples of long-lived individuals. J. Gerontol. A Biol. Sci. Med. Sci. 67, 470-479. doi:10.1093/gerona/gls089
22. Panda, A., Qian, F., Mohanty, S., van Duin, D., Newman, F. K., and Zhang, L. (2010). Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J. Immunol. 184, 2518-2527. doi:10.4049/jimmunol.0901022
23. Rothberg, M. B., Haessler, S. D., and Brown, R. B. (2008). Complications of viral influenza. Am. J. Med. 121, 258-264. doi:10.1016/j.amjmed.2007.10.040
24. Sasaki, S., Sullivan, M., Narvaez, C. F., Holmes, T. H., Furman, D., and Zheng, N. Y. (2011). Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J. Clin. Invest. 121, 3109-3119. doi:10.1172/JCI57834
25. Saurwein-Teissl, M., Lung, T. L., Marx, F., Gschosser, C., Asch, E., and Blasko, I. (2002). Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J. Immunol. 168, 5893-5899.
26. Shaw, A. C., Joshi, S., Greenwood, H., Panda, A., and Lord, J. M. (2010). Aging of the innate immune system. Curr. Opin. Immunol. 22, 507-513. doi:10.1016/j.coi.2010.05.003
27. Shaw, A. C., Panda, A., Joshi, S. R., Qian, F., Allore, H. G., and Montgomery, R. R. (2011). Dysregulation of human Toll-like receptor function in aging. Ageing Res. Rev. 10, 346-353. doi:10.1016/j.arr.2010.10.007
28. Wikby, A., Ferguson, F., Forsey, R., Thompson, J., Strindhall, J., and Lofgren, S. (2005). An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J. Gerontol. A Biol. Sci. Med. 60, 556-565. doi:10.1093/gerona/60.5.556
29. Yager, E. J., Ahmed, M., Lanzer, K., Randall, T. D., Woodland, D. L., and Blackman, M. A. (2008). Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus. J. Exp. Med. 205, 711-723. doi:10.1084/jem.20071140